Aclaris Therapeutics US00461U1051
Aclaris Therapeutics US00461U1051
Nagarro SE: All Nag Beteiligungs-GmbH & Co. KG, buy
Aurubis AG: Release according to Article 40 Section 1 of the ...
Nemetschek SE: Release according to Article 40 Section 1 of the ...
Dr. Peter Laier to become new FORVIA HELLA’s Chief Executive ...
VanEck Vietnam ETF US92189F8178
The Carlyle Group US14316J1088
Kezar Life Sciences US49372L1008